Table 3.
Effect of allicin on food intake in hypertensive rats.
| Group(s) | Food intake (g/d) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0th week | 1st week | 2nd week | 3rd week | 4th week | 5th week | 6th week | 7th week | 8th week | |
| I | 14.00 ± 3.91 | 13.00 ± 1.79 | 11.50 ± 1.64 | 9.00 ± 2.60 | 12.00 ± 2.39 | 10.60 ± 2.06 | 13.80 ± 1.62 | 15.60 ± 1.60 | 17.30 ± 1.17* |
| II | 12.30 ± 2.67 | 8.50 ± 1.48 | 9.00 ± 2.12 | 10.00 ± 2.77 | 6.50 ± 1.71 | 8.30 ± 1.83 | 11.40 ± 1.92 | 9.20 ± 1.51 | 7.80 ± 1.84 |
| III | 15.30 ± 1.98 | 9.33 ± 1.57 | 9.00 ± 1.74 | 8.33 ± 2.09 | 10.50 ± 2.48 | 8.50 ± 3.43 | 11.20 ± 3.22 | 15.00 ± 4.37 | 13.66 ± 3.11 |
| IV | 18.30 ± 17.70 | 12.60 ± 1.96 | 7.90± 1.55 | 8.00 ± 2.34 | 7.66 ± 1.68 | 11.33 ± 2.05 | 13.40 ± 1.47 | 15.70 ± 1.31 | 17.66 ± 2.80* |
Data are expressed as mean ± SEM (n = 6). Significance was determined by two-way ANOVA followed by Bonferroni post-tests. A p value of <0.05 was considered significant. All groups were compared with group II.
ANOVA, analysis of variance; group I, normal control animals; group II, hypertensive animals; group III, nicorandil-treated animals; group IV, allicin-treated animals; SEM, standard error of the mean.
*
Shows the level of significance (*p < 0.05).